Chris Stevens
Keine laufenden Positionen mehr
Karriereverlauf von Chris Stevens
Ehemalige bekannte Positionen von Chris Stevens
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2021 | 15.07.2022 |
Arsanis, Inc.
 Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2016 | 15.01.2019 |
Alnara Pharmaceuticals, Inc.
 Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01.01.2009 | 01.01.2011 |
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
CB Biomedical, Inc.
 CB Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services CB Biomedical, Inc. develops and produces novel bioartificial organs based on proprietary mammalian cell and semi permeable membrane technologies. The company is headquartered in Lexington, MA | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| Harvard Medical School | Corporate Officer/Principal | - | - |
Ausbildung von Chris Stevens
| The University of North Carolina at Charlotte | Undergraduate Degree |
| University of Miami | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
Operativ
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ASTRIA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | Health Technology |
Alnara Pharmaceuticals, Inc.
Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA. | Health Technology |
CB Biomedical, Inc.
CB Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services CB Biomedical, Inc. develops and produces novel bioartificial organs based on proprietary mammalian cell and semi permeable membrane technologies. The company is headquartered in Lexington, MA | Commercial Services |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Chris Stevens
- Erfahrung